| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 11, 2025 | WRBY Warby Parker Inc. | Moon Youngme E65 | Director | Sell | 38,832 | $29.07 | $1,128,846.24 | -58.9% | -15.9% | - | |
| Dec 11, 2025 | EW Edwards Lifesciences Corp | Chopra Daveen59 | Cvp, Tmtt &Surgical | Sell | 2,000 | $84.38 | $168,750.20 | -5.8% | +1.0% | - | |
| Dec 11, 2025 | NVNO Envveno Medical Corp | Duhay Francis | Director | Sell | 4,900 | $0.36 | $1,742.44 | -5.0% | +0.1% | - | |
| Dec 11, 2025 | AXGN Axogen, Inc. | Began Marc A | EVP &General Counsel | Sell | 13,222 | $30.00 | $396,660.00 | -42.0% | +7.7% | - | |
| Dec 11, 2025 | LUCY Innovative Eyewear Inc | Galkin Vladimir45 | 10% Owner | Buy | 58,723 | $1.50 | $88,255.34 | +3.2% | -29.6% | - | |
| Dec 11, 2025 | INCY Incyte Corp | Mayes Patrick A | EVP &Chief Scientific Officer | Sell | 5,808 | $95.55 | $554,965.44 | -4.6% | -1.5% | - | |
| Dec 10, 2025 | ATEC Alphatec Holdings, Inc. | Sponsel David61 | EVP, Sales | Sell | 21,106 | $20.79 | $438,793.74 | -4.6% | -40.1% | - | |
| Dec 10, 2025 | ATEC Alphatec Holdings, Inc. | Hunsaker Craig E61 | EVP, People &Culture | Sell | 32,584 | $20.84 | $679,050.56 | -2.5% | -40.1% | - | |
| Dec 10, 2025 | AXGN Axogen, Inc. | Dale Michael D64 | Chief Executive Officer | Sell | 25,000 | $30.00 | $750,000.00 | -28.2% | +2.3% | - | |
| Dec 10, 2025 | SERA Sera Prognostics, Inc. | Harrison Robert Gardner74 | Chief Information Officer | Sell | 616 | $3.31 | $2,038.96 | -0.7% | -46.8% | - | |
| Dec 10, 2025 | SERA Sera Prognostics, Inc. | Aerts Austin77 | Chief Financial Officer | Sell | 873 | $3.31 | $2,889.63 | -0.3% | -46.8% | - | |
| Dec 10, 2025 | SERA Sera Prognostics, Inc. | Kearney Paul78 | Chief Data Officer | Sell | 1,213 | $3.31 | $4,015.03 | -0.7% | -46.8% | - | |
| Dec 10, 2025 | UFPT Ufp Technologies Inc | Holt Jason | Vice President | Sell | 100 | $213.58 | $21,358.00 | -1.3% | +0.7% | - | |
| Dec 10, 2025 | SERA Sera Prognostics, Inc. | Lindgardt Zhenya75 | Chief Executive Officer | Sell | 4,155 | $3.31 | $13,753.05 | -0.5% | -46.8% | - | |
| Dec 10, 2025 | ISRG Intuitive Surgical Inc | Curet Myriam56 | EVP &Chief Medical Officer | Sell | 104 | $559.90 | $58,229.60 | -100% | -12.6% | - | |
| Dec 10, 2025 | SERA Sera Prognostics, Inc. | Boniface John J.55 | Chief Scientific Officer | Sell | 1,332 | $3.31 | $4,408.92 | -0.9% | -46.8% | - | |
| Dec 10, 2025 | SERA Sera Prognostics, Inc. | Jackson Benjamin81 | General Counsel | Sell | 892 | $3.31 | $2,952.52 | -0.7% | -46.8% | - | |
| Dec 10, 2025 | EW Edwards Lifesciences Corp | Bobo Donald E Jr64 | Cvp,Strategy/ Corp Development | Sell | 11,340 | $83.83 | $950,581.17 | -18.4% | +2.2% | - | |
| Dec 10, 2025 | QDEL Quidelortho Corp | Rhoads Ann D47 | Director | Buy | 750 | $28.28 | $21,206.25 | +5.3% | -32.9% | - | |
| Dec 10, 2025 | EW Edwards Lifesciences Corp | Zovighian Bernard J55 | CEO | Sell | 25,350 | $84.95 | $2,153,373.46 | -21.3% | +2.2% | - | |
| Dec 10, 2025 | SNWV Sanuwave Health, Inc. | Manchester Management Co LLC | Director By Deputization | Sell | 144,810 | $30.73 | $4,450,061.36 | -5.2% | -24.8% | - | |
| Dec 9, 2025 | EKSO Ekso Bionics Holdings, Inc. | Wong Jerome55 | Chief Financial Officer | Sell | 1,238 | $4.70 | $5,818.60 | -4.8% | +149.0% | - | |
| Dec 9, 2025 | AXGN Axogen, Inc. | Dale Michael D64 | Chief Executive Officer | Sell | 61,463 | $31.21 | $1,918,137.30 | -41.0% | -4.3% | - | |
| Dec 9, 2025 | BLFS Biolife Solutions Inc | Mathew Aby J.68 | EVP &Chief Scientific Officer | Sell | 631 | $25.13 | $15,857.03 | -0.2% | -19.6% | - | |
| Dec 9, 2025 | IRMD Iradimed Corp | Hawkins James B60 | - | Sell | 3,000 | $96.61 | $289,837.50 | -9.5% | +3.6% | - |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.